Impact of age on neurofilament light chain in Friedreich ataxia: a 1-year longitudinal study. [PDF]
Brain CommunPetrillo S +9 more
europepmc +1 more source
Editorial: The mechanistic investigation and emerging therapies for Friedreich's ataxia. [PDF]
Front PharmacolDong Y, Chandran V, Soragni E, Lynch DR.
europepmc +1 more source
Friedreich ataxia: what can we learn from non-GAA repeat mutations? [PDF]
Neurodegener Dis ManagLynch DR, Shen M, Wilson RB.
europepmc +1 more source
Hereditary Ataxias: From Pathogenesis and Clinical Features to Neuroimaging, Fluid, and Digital Biomarkers-A Scoping Review. [PDF]
Int J Mol SciBernardi E +5 more
europepmc +1 more source
Development of a secretable frataxin for enhanced efficacy in treating Friedreich's Ataxia. [PDF]
Mol Ther AdvDuBreuil DM +9 more
europepmc +1 more source
Friedreich Ataxia: An (Almost) 30-Year History After Gene Discovery. [PDF]
Neurol GenetPandolfo M.
europepmc +1 more source
Ferritin in ferroptosis: Implications for neurodegenerative diseases (Review). [PDF]
Int J Mol MedChen W, Tian H, Wei R, Chen X, Jia Y.
europepmc +1 more source
Redox homeostasis in ferroptosis and aging: a causal role for fard-1 and dhs-25 in Caenorhabditis elegans. [PDF]
Redox BiolPensotti R +11 more
europepmc +1 more source
Pharmacokinetics and Pharmacodynamics of Nomlabofusp in Non-clinical Studies of Friedreich's Ataxia. [PDF]
AAPS JDe Toni F +11 more
europepmc +1 more source